USA • New York Stock Exchange • NYSE:CNMD • US2074101013
The current stock price of CNMD is 40.66 USD. In the past month the price decreased by -6.31%. In the past year, price decreased by -38.79%.
ChartMill assigns a fundamental rating of 5 / 10 to CNMD. Both the profitability and the financial health of CNMD get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months CNMD reported a non-GAAP Earnings per Share(EPS) of 4.61. The EPS increased by 10.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.77% | ||
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| Debt/Equity | 0.85 |
12 analysts have analysed CNMD and the average price target is 49.57 USD. This implies a price increase of 21.92% is expected in the next year compared to the current price of 40.66.
For the next year, analysts expect an EPS growth of -1.76% and a revenue growth 0.29% for CNMD
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.02 | 189.676B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.95 | 168.855B | ||
| SYK | STRYKER CORP | 23.97 | 138.597B | ||
| BSX | BOSTON SCIENTIFIC CORP | 22.17 | 115.097B | ||
| BDX | BECTON DICKINSON AND CO | 13.75 | 58.942B | ||
| IDXX | IDEXX LABORATORIES INC | 43.44 | 51.391B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.38 | 45.321B | ||
| RMD | RESMED INC | 21.75 | 38.981B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.39 | 37.494B | ||
| DXCM | DEXCOM INC | 27.76 | 27.258B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
CONMED CORP
11311 Concept Boulevard
Largo FLORIDA 33773 US
CEO: Curt R. Hartman
Employees: 3900
Phone: 17272142974
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
The current stock price of CNMD is 40.66 USD. The price increased by 1.83% in the last trading session.
CONMED CORP (CNMD) has a dividend yield of 2%. The yearly dividend amount is currently 0.8.
CNMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for CONMED CORP (CNMD) is 8.82. This is based on the reported non-GAAP earnings per share of 4.61 and the current share price of 40.66 USD.
The next ex-dividend date for CONMED CORP (CNMD) is September 15, 2025.
CONMED CORP (CNMD) has a market capitalization of 1.26B USD. This makes CNMD a Small Cap stock.